Oseltamivir Use in Lactating Mothers
Oseltamivir is safe to use during breastfeeding and should not be discontinued for nursing mothers who require antiviral treatment for influenza. 1
Safety Profile During Lactation
The FDA drug label confirms that oseltamivir and its active metabolite (oseltamivir carboxylate) are present in human milk at low levels considered unlikely to lead to toxicity in breastfed infants 2. Postmarketing surveillance has not identified any serious adverse effects in breastfed infants whose mothers took oseltamivir 2.
Breastfeeding should be strongly encouraged even when the mother has influenza, as human milk provides protective benefits through innate antiviral mechanisms (specifically type 1 interferons) and influenza-specific immunoglobulin A 1. If direct breastfeeding is not possible due to maternal illness severity, the mother should pump and feed expressed breast milk 1.
Dosing for Lactating Mothers
Treatment (5 days):
- 75 mg orally twice daily 1
- Can be taken without regard to meals, though administration with food may improve gastrointestinal tolerability 1
Chemoprophylaxis (10 days):
- 75 mg orally once daily 1
Clinical Reasoning
When a breastfeeding mother requires antiviral agents, oral oseltamivir is the preferred choice 1. The AAP guidelines from 2018 explicitly state that "none of the antiviral agents are reasons to discontinue breastfeeding" 1.
The benefits of treating maternal influenza and continuing breastfeeding far outweigh theoretical risks to the infant. Untreated influenza in the mother poses greater risks through:
- Direct viral transmission to the infant
- Loss of protective antibodies that would be transferred through breast milk
- Maternal complications that could compromise infant care
Important Caveats
- No dose adjustment is needed for lactating mothers compared to standard adult dosing 1
- The drug does not affect milk production 2
- Renal function should be assessed if the mother has kidney disease, as dose adjustment may be needed (for creatinine clearance 10-30 mL/min: 75 mg once daily for treatment) 1
- Most common maternal side effects are nausea and vomiting, which can be minimized by taking the medication with food 1
The decision to use oseltamivir should consider the mother's clinical need for treatment, but breastfeeding continuation should be maintained regardless of this decision 2.